Mabpharm Limited (HKG:2181)
0.5150
+0.0150 (3.00%)
Oct 9, 2026, 11:38 AM HKT
| Market Cap | 2.08B -24.6% |
| Revenue (ttm) | 888.77M +81.6% |
| Net Income | 98.82M |
| EPS | 0.02 |
| Shares Out | 4.12B |
| PE Ratio | 22.67 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 80,000 |
| Open | 0.5150 |
| Previous Close | 0.5000 |
| Day's Range | 0.5000 - 0.5150 |
| 52-Week Range | 0.3100 - 0.8100 |
| Beta | 0.60 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 27, 2026 |